BioSpace News Archive

Generation Bio Co. (Nasdaq: GBIO), a biotechnology company innovating genetic medicines for people living with rare and prevalent diseases, reported recent business highlights and second quarter 2021 financial results.

Aileron Therapeutics (NASDAQ:ALRN), a chemoprotection oncology company focused on fundamentally transforming the experience of chemotherapy for cancer patients, today reported business highlights and financial results for the second quarter ended June 30, 2021.

Milestone Pharmaceuticals Inc. today reported financial results for the second quarter ended June 30, 2021 and provided a clinical and corporate update.

ProQR Therapeutics N.V., a company dedicated to changing lives through the creation of transformative RNA therapies for genetic eye diseases, announced that Company management will present at the upcoming HC Wainwright Ophthalmology Virtual Conference.

Mirus Bio, today announces the launch of the TransIT ® VirusGEN ® GMP product line.

Shattuck Labs, Inc. (Shattuck) (NASDAQ: STTK), a clinical-stage biotechnology company pioneering the development of bi-functional fusion proteins as a new class of biologic medicine for the treatment of patients with cancer and autoimmune disease, today reported financial results for the second quarter ended June 30, 2021 and provided recent business highlights.

BELLUS Health Inc., a clinical-stage biopharmaceutical company developing novel therapeutics for the treatment of refractory chronic cough and other hypersensitization-related disorders, reported its financial and operating results for the second quarter ending June 30, 2021.

Helius Medical Technologies, Inc., a neurotech company focused on neurological wellness, announced that, effective August 10, 2021, its independent directors approved an equity award under Helius’ 2021 Inducement Plan, as a material inducement to an individual entering into employment with the Company.

NeuroOne Medical Technologies Corporation (NASDAQ: NMTC) (NeuroOne or the Company), a medical technology company focused on improving surgical care options and outcomes for patients suffering from neurological disorders, announces today it will host a conference call to discuss financial results for its third quarter ended June 30, 2021, on August 13, 2021, at 9:00 AM ET.

StageZero Life Sciences announced that it will release its second quarter 2021 operational results before the market open on Tuesday, August 17, 2021.